Skip to main content
. 2015 Aug 27;2015(8):CD007603. doi: 10.1002/14651858.CD007603.pub2

4. Topical CsA versus placebo in people undergoing high‐risk keratoplasty.

Outcome Topical CsA Placebo RR (95% CI)
Graft rejection (immune reactions) at 1 year 7/39 (17.9%) 7/39 (17.9%) 1.00 (0.39 to 2.58)

Data from Sinha 2010

CsA: cyclosporine A
 RR: risk ratio
 CI: confidence interval